David Hung - Apr 4, 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
PRESIDENT AND CEO, Director, 10%+ Owner
Signature
/s/ Stephen Dang, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Apr 4, 2025
Transactions value $
$820,220
Form type
4
Date filed
4/8/2025, 09:30 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Purchase $333K +200K +0.34% $1.66 58.5M Apr 4, 2025 Direct F1
transaction NUVB Class A Common Stock Purchase $488K +300K +0.51% $1.63 58.8M Apr 7, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2 ) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.